Intestinal Ultrasound–Defined Active IBD in Pregnancy and Adverse Obstetric Outcomes

The use of intestinal ultrasound (IUS) to monitor disease activity in pregnant women with inflammatory bowel disease (IBD) has been shown to have significant prognostic value in predicting adverse obstetric outcomes. The findings of the study highlight the following key points:

### 1. **Role of IUS in Defining Active IBD:**

• IUS was used to assess disease activity in pregnant women with IBD, focusing on parameters like **bowel wall thickness** and **hyperemia** (increased blood flow in the bowel wall).
• Active disease as detected by IUS was strongly associated with adverse pregnancy outcomes.

### 2. **Adverse Obstetric Outcomes Linked to Active IBD:**

• **Preterm Delivery:** Pregnant women with active IBD on IUS had a higher likelihood of delivering preterm.
• **Low Birth Weight (LBW):** Infants born to mothers with active IBD were more likely to have low birth weights.
• **NICU Admission:** Newborns from mothers with active IBD required neonatal intensive care unit (NICU) admission more frequently.
• **Preeclampsia:** Active IBD was associated with a higher risk of preeclampsia, a pregnancy complication marked by high blood pressure and potential organ damage.
• **Gestational Diabetes:** There was also a link between active IBD and an increased risk of gestational diabetes.

### 3. **Independence from Clinical and Biochemical Measures:**

• The associations between IUS-defined active IBD and adverse outcomes were **independent of clinical symptoms or biochemical markers**.
• Clinical and biochemical measures often showed **poor concordance** with IUS findings, suggesting that IUS provides unique and valuable information that may not be captured by traditional methods.

### 4. **Prognostic Value of IUS:**

• The study underscores the prognostic utility of IUS in pregnancy, as it enables early identification of women at higher risk for adverse maternal and neonatal outcomes.
• IUS serves as a **safe, non-invasive tool** that can guide the management of IBD in pregnant women, potentially improving outcomes.

### 5. **Clinical Implications:**

• The findings support the integration of IUS into routine care for pregnant women with IBD.
• Regular monitoring with IUS may allow for timely interventions to mitigate risks associated with active disease.

In summary, intestinal ultrasound-defined active IBD in pregnancy is strongly associated with adverse obstetric outcomes, including preterm delivery, low birth weight, NICU admission, preeclampsia, and gestational diabetes. The study highlights the unique value of IUS as a reliable, non-invasive tool for monitoring disease activity and guiding clinical management to improve both maternal and neonatal outcomes.